A Multi-Center, Open label, Repeated Dose Range Finding Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Efficacy of an Anti-IL-1? Monoclonal Antibody (ACZ885) Given Subcutaneously in Pediatric Subjects with Active Systemic
Read time: 1 mins
Last updated:14th Oct 2010
To evaluate the safety, tolerability and immunogenicity of sc administration of ACZ885 in pediatric subjects with active Systemic Juvenile Idiopathic Arthritis (SJIA).
|Study start date||2010-10-14|